ArticleCancers2019

Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients.

Ondrej Fiala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.